Biological Psychiatry, ISSN 0006-3223, 07/2018, Volume 84, Issue 1, pp. e3 - e6
Journal Article
Physics Letters B, ISSN 0370-2693, 09/2016, Volume 760, Issue C, pp. 647 - 665
A search for heavy long-lived charged -hadrons is reported using a data sample corresponding to 3.2 fb of proton–proton collisions at collected by the ATLAS...
Physics | High Energy Physics - Experiment | Fysik | Subatomär fysik | Physical Sciences | Subatomic Physics | Naturvetenskap | Natural Sciences
Physics | High Energy Physics - Experiment | Fysik | Subatomär fysik | Physical Sciences | Subatomic Physics | Naturvetenskap | Natural Sciences
Journal Article
Journal of Molecular Structure, ISSN 0022-2860, 2009, Volume 935, Issue 1, pp. 161 - 166
Two chiral complexes, [CuCl( , -DIOP)] ( ) and [CdCl ( , -DIOP)] ( ), have been synthesized by reaction of CuCl or CdCl with chiral diphosphine ligand , -DIOP...
Copper (I) | Helix | R, R-DIOP | Chiral complex | Cadmium (II) | Binuclear | R,R-DIOP
Copper (I) | Helix | R, R-DIOP | Chiral complex | Cadmium (II) | Binuclear | R,R-DIOP
Journal Article
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 2010, Volume 18, Issue 20, pp. 7203 - 7211
In a continuing investigation into the pharmacophores and structure–activity relationship (SAR) of (3′ ,4′ )-3′,4′-di- -( )-camphanoyl-(+)- -khellactone (DCK)...
Anti-HIV activity | Structure–activity relationship (SAR) | 1′-Thia-4-methyl-(3′ R,4′ R)-3′,4′-di- O-( S)-camphanoyl-(+)- cis-khellactone (DCK) analogs | 2′-Monomethyl-4-methyl-(3′ R,4′ R)-3′,4′-di- O-( S)-camphanoyl-(+)- cis-khellactone (DCK) analogs | 2′-Monomethyl-4-methyl-(3′R,4′R)-3′, 4′-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK) analogs | 1′-Thia-4-methyl-(3′R,4′R)-3′,4′-di-O-(S) -camphanoyl-(+)-cis-khellactone (DCK) analogs | 1 '-Thia-4-methyl-(3 ' R,4 ' R)-3 ',4 '-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK) analogs | 2 '-Monomethyl-4-methyl-(3 ' R,4 ' R)-3 ',4 '-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK) analogs | Structure-activity relationship (SAR) | CHEMISTRY, MEDICINAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHEMISTRY, ORGANIC | DERIVATIVES | DNA Replication - drug effects | HIV-1 - drug effects | Humans | Molecular Conformation | Crystallography, X-Ray | Structure-Activity Relationship | Camphor - therapeutic use | Anti-HIV Agents - chemical synthesis | Acquired Immunodeficiency Syndrome - drug therapy | Lactones - therapeutic use | Anti-HIV Agents - chemistry | Camphor - analogs & derivatives | Lactones - chemical synthesis | Camphor - chemical synthesis | Drug Design | Anti-HIV Agents - therapeutic use | Camphor - chemistry | Lactones - chemistry | 4′-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK) analogs | 2′-Monomethyl-4-methyl-(3′R, 4′R)-3 | 1′-Thia-4-methyl-(3′R,4′R)-3
Anti-HIV activity | Structure–activity relationship (SAR) | 1′-Thia-4-methyl-(3′ R,4′ R)-3′,4′-di- O-( S)-camphanoyl-(+)- cis-khellactone (DCK) analogs | 2′-Monomethyl-4-methyl-(3′ R,4′ R)-3′,4′-di- O-( S)-camphanoyl-(+)- cis-khellactone (DCK) analogs | 2′-Monomethyl-4-methyl-(3′R,4′R)-3′, 4′-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK) analogs | 1′-Thia-4-methyl-(3′R,4′R)-3′,4′-di-O-(S) -camphanoyl-(+)-cis-khellactone (DCK) analogs | 1 '-Thia-4-methyl-(3 ' R,4 ' R)-3 ',4 '-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK) analogs | 2 '-Monomethyl-4-methyl-(3 ' R,4 ' R)-3 ',4 '-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK) analogs | Structure-activity relationship (SAR) | CHEMISTRY, MEDICINAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHEMISTRY, ORGANIC | DERIVATIVES | DNA Replication - drug effects | HIV-1 - drug effects | Humans | Molecular Conformation | Crystallography, X-Ray | Structure-Activity Relationship | Camphor - therapeutic use | Anti-HIV Agents - chemical synthesis | Acquired Immunodeficiency Syndrome - drug therapy | Lactones - therapeutic use | Anti-HIV Agents - chemistry | Camphor - analogs & derivatives | Lactones - chemical synthesis | Camphor - chemical synthesis | Drug Design | Anti-HIV Agents - therapeutic use | Camphor - chemistry | Lactones - chemistry | 4′-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK) analogs | 2′-Monomethyl-4-methyl-(3′R, 4′R)-3 | 1′-Thia-4-methyl-(3′R,4′R)-3
Journal Article
The European Physical Journal C, ISSN 1434-6044, 8/2016, Volume 76, Issue 8, pp. 1 - 19
Modified gravity theories have the potential of explaining the recent acceleration of the Universe without resorting to the mysterious concept of dark energy....
Nuclear Physics, Heavy Ions, Hadrons | Measurement Science and Instrumentation | Nuclear Energy | Quantum Field Theories, String Theory | Physics | Elementary Particles, Quantum Field Theory | Astronomy, Astrophysics and Cosmology | MATTER | F(R | ENERGY COMPONENT | DYNAMICAL INSTABILITY | CONSTANT | SUPERNOVAE | EQUATION | LAMBDA | PHYSICS, PARTICLES & FIELDS | Analysis | Dark energy | Gravity | Physics and Astronomy (miscellaneous) | General Relativity and Quantum Cosmology | Engineering (miscellaneous) | High Energy Physics - Theory | Astrophysics - Cosmology and Nongalactic Astrophysics
Nuclear Physics, Heavy Ions, Hadrons | Measurement Science and Instrumentation | Nuclear Energy | Quantum Field Theories, String Theory | Physics | Elementary Particles, Quantum Field Theory | Astronomy, Astrophysics and Cosmology | MATTER | F(R | ENERGY COMPONENT | DYNAMICAL INSTABILITY | CONSTANT | SUPERNOVAE | EQUATION | LAMBDA | PHYSICS, PARTICLES & FIELDS | Analysis | Dark energy | Gravity | Physics and Astronomy (miscellaneous) | General Relativity and Quantum Cosmology | Engineering (miscellaneous) | High Energy Physics - Theory | Astrophysics - Cosmology and Nongalactic Astrophysics
Journal Article
ISSN 1759-9954, 9/2017, Volume 8, Issue 37, pp. 5726 - 5733
The double helix is one of the most basic and exquisite architectures in nature, and thus has received much attention in multiple disciplines. However, the...
Journal Article
Forensic Science International, ISSN 0379-0738, 2014, Volume 246, pp. 72 - 78
Highlights • Chiral determination of methamphetamine (MA) and amphetamine (AM) in urine was achieved. • A validated, simple, and rapid LC–MS/MS method was...
Pathology | Urine | R/S-Amphetamine | R/S-Methamphetamine | LC–MS/MS | Chiral separation | LC-MS/MS | MEDICINE, LEGAL | QUANTIFICATION | STATIONARY PHASES | DESIGNER DRUGS | ENANTIOMERIC DETERMINATION | DERIVATIZATION | PERFORMANCE LIQUID-CHROMATOGRAPHY | EXTRACTION | BETA-CYCLODEXTRIN | CHROMATOGRAPHY-MASS SPECTROMETRY | HAIR SPECIMENS | Amphetamine-Related Disorders - diagnosis | Substance Abuse Detection - methods | Spectrometry, Mass, Electrospray Ionization - methods | Amphetamine - urine | Amphetamine-Related Disorders - urine | Humans | Amphetamine - chemistry | Central Nervous System Stimulants - chemistry | Central Nervous System Stimulants - urine | Methamphetamine - urine | Methamphetamine - chemistry | Chromatography, Liquid - methods | Usage | Methamphetamine | Liquid chromatography | Research | Properties | Mass spectrometry | Index Medicus | Analytical chemistry | Drugs | Separation | Methyl alcohol | Linearity | Assessments | Ingestion
Pathology | Urine | R/S-Amphetamine | R/S-Methamphetamine | LC–MS/MS | Chiral separation | LC-MS/MS | MEDICINE, LEGAL | QUANTIFICATION | STATIONARY PHASES | DESIGNER DRUGS | ENANTIOMERIC DETERMINATION | DERIVATIZATION | PERFORMANCE LIQUID-CHROMATOGRAPHY | EXTRACTION | BETA-CYCLODEXTRIN | CHROMATOGRAPHY-MASS SPECTROMETRY | HAIR SPECIMENS | Amphetamine-Related Disorders - diagnosis | Substance Abuse Detection - methods | Spectrometry, Mass, Electrospray Ionization - methods | Amphetamine - urine | Amphetamine-Related Disorders - urine | Humans | Amphetamine - chemistry | Central Nervous System Stimulants - chemistry | Central Nervous System Stimulants - urine | Methamphetamine - urine | Methamphetamine - chemistry | Chromatography, Liquid - methods | Usage | Methamphetamine | Liquid chromatography | Research | Properties | Mass spectrometry | Index Medicus | Analytical chemistry | Drugs | Separation | Methyl alcohol | Linearity | Assessments | Ingestion
Journal Article
Lung Cancer, ISSN 0169-5002, 06/2017, Volume 108, pp. 228 - 231
Acquired epidermal growth factor receptor (EGFR) resistance mutations to osimertinib are common, including the EGFR C797S that abolishes the covalent binding...
ctDNA assay | Solvent front mutation | EGFR G796 | EGFR+ lung cancer | Osimertinib | EGFR L792 | EGFR C797 | LEVEL | EGFR plus lung cancer | LUNG-CANCER | ENTRECTINIB | ONCOLOGY | RESPIRATORY SYSTEM | RESISTANCE | CRIZOTINIB | INHIBITORS | AZD9291 | REVEALS | Lung Neoplasms - drug therapy | Humans | Molecular Conformation | ErbB Receptors - genetics | Antineoplastic Agents - therapeutic use | Carcinoma, Non-Small-Cell Lung - diagnosis | Piperazines - chemistry | Protein Kinase Inhibitors - chemistry | Female | Disease Models, Animal | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Models, Molecular | Piperazines - therapeutic use | Antineoplastic Agents - chemistry | Animals | ErbB Receptors - chemistry | Protein Kinase Inhibitors - therapeutic use | Alleles | Protein Binding | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Lung Neoplasms - diagnosis | Neoplasm Staging | Amino Acid Substitution
ctDNA assay | Solvent front mutation | EGFR G796 | EGFR+ lung cancer | Osimertinib | EGFR L792 | EGFR C797 | LEVEL | EGFR plus lung cancer | LUNG-CANCER | ENTRECTINIB | ONCOLOGY | RESPIRATORY SYSTEM | RESISTANCE | CRIZOTINIB | INHIBITORS | AZD9291 | REVEALS | Lung Neoplasms - drug therapy | Humans | Molecular Conformation | ErbB Receptors - genetics | Antineoplastic Agents - therapeutic use | Carcinoma, Non-Small-Cell Lung - diagnosis | Piperazines - chemistry | Protein Kinase Inhibitors - chemistry | Female | Disease Models, Animal | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Models, Molecular | Piperazines - therapeutic use | Antineoplastic Agents - chemistry | Animals | ErbB Receptors - chemistry | Protein Kinase Inhibitors - therapeutic use | Alleles | Protein Binding | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Lung Neoplasms - diagnosis | Neoplasm Staging | Amino Acid Substitution
Journal Article
Tetrahedron: Asymmetry, ISSN 0957-4166, 06/2013, Volume 24, Issue 11, pp. 633 - 637
Novel total syntheses of ( )-(−)-pyridindolol , ( )-(−)-pyridindolol K1 , and ( )-(−)-pyridindolol K2 are described. By using -tryptophan methyl ester and (...
CONVENIENT SYNTHESIS | PYRIDINDOLOL | D,L-PYRIDINDOLOL | CHEMISTRY, ORGANIC | CHEMISTRY, PHYSICAL | INHIBITOR | L-ASCORBIC-ACID | GALACTOSIDASE | ALKALOIDS | CHEMISTRY, INORGANIC & NUCLEAR
CONVENIENT SYNTHESIS | PYRIDINDOLOL | D,L-PYRIDINDOLOL | CHEMISTRY, ORGANIC | CHEMISTRY, PHYSICAL | INHIBITOR | L-ASCORBIC-ACID | GALACTOSIDASE | ALKALOIDS | CHEMISTRY, INORGANIC & NUCLEAR
Journal Article
The European Physical Journal C, ISSN 1434-6044, 5/2018, Volume 78, Issue 5, pp. 1 - 22
We consider the Palatini formulation of f(R, T) gravity theory, in which a non-minimal coupling between the Ricci scalar and the trace of the energy-momentum...
Nuclear Physics, Heavy Ions, Hadrons | Measurement Science and Instrumentation | Nuclear Energy | Quantum Field Theories, String Theory | Physics | Elementary Particles, Quantum Field Theory | Astronomy, Astrophysics and Cosmology | THERMODYNAMICS | PARTICLE CREATION | ENERGY-MOMENTUM | STABILITY | F R | DARK-MATTER | CONSTANT | CONSTRAINTS | SUPERNOVAE | MODIFIED GRAVITY | PHYSICS, PARTICLES & FIELDS | Gravitation | Conformal mapping | Energy conservation | Independent variables | Astronomical models | Cosmology | Equations of motion | Gravity | General Relativity and Quantum Cosmology | Nuclear and particle physics. Atomic energy. Radioactivity | Astrophysics | High Energy Physics - Theory | Astrophysics - Cosmology and Nongalactic Astrophysics
Nuclear Physics, Heavy Ions, Hadrons | Measurement Science and Instrumentation | Nuclear Energy | Quantum Field Theories, String Theory | Physics | Elementary Particles, Quantum Field Theory | Astronomy, Astrophysics and Cosmology | THERMODYNAMICS | PARTICLE CREATION | ENERGY-MOMENTUM | STABILITY | F R | DARK-MATTER | CONSTANT | CONSTRAINTS | SUPERNOVAE | MODIFIED GRAVITY | PHYSICS, PARTICLES & FIELDS | Gravitation | Conformal mapping | Energy conservation | Independent variables | Astronomical models | Cosmology | Equations of motion | Gravity | General Relativity and Quantum Cosmology | Nuclear and particle physics. Atomic energy. Radioactivity | Astrophysics | High Energy Physics - Theory | Astrophysics - Cosmology and Nongalactic Astrophysics
Journal Article
MATHEMATICAL PROBLEMS IN ENGINEERING, ISSN 1024-123X, 2019, Volume 2019
In this paper, using the properties of r-Hankel and r-Toeplitz matrices, combining the properties of exponential form, we shall study the spectral norms of...
FIBONACCI | MATHEMATICS, INTERDISCIPLINARY APPLICATIONS | CIRCULANT MATRICES | ENGINEERING, MULTIDISCIPLINARY | Norms | Numbers | Applied mathematics | Eigen values
FIBONACCI | MATHEMATICS, INTERDISCIPLINARY APPLICATIONS | CIRCULANT MATRICES | ENGINEERING, MULTIDISCIPLINARY | Norms | Numbers | Applied mathematics | Eigen values
Journal Article
Chinese Journal of Chemistry, ISSN 1001-604X, 06/2015, Volume 33, Issue 6, pp. 683 - 687
A synthesis of (R)‐muscone (1), a valuable musk odorant, is presented. The stereogenic center of muscone was introduced from methyl...
macrocycles | (R)‐5‐bromo‐4‐methylpentanoate | chiral pool | fragrances | muscone | (R)-5-bromo-4-methylpentanoate | 3-CARBON RING EXPANSION | ASYMMETRIC-SYNTHESIS | SUBSTITUENT CONTROL | OPTICAL RESOLUTION | ENANTIOSELECTIVE SYNTHESIS | EFFICIENT SYNTHESIS | BETA-KETO-ESTERS | MACROCYCLIC KETONES | CHEMISTRY, MULTIDISCIPLINARY | STEREOSELECTIVE-SYNTHESIS | CONJUGATE ADDITION | Biological products industry
macrocycles | (R)‐5‐bromo‐4‐methylpentanoate | chiral pool | fragrances | muscone | (R)-5-bromo-4-methylpentanoate | 3-CARBON RING EXPANSION | ASYMMETRIC-SYNTHESIS | SUBSTITUENT CONTROL | OPTICAL RESOLUTION | ENANTIOSELECTIVE SYNTHESIS | EFFICIENT SYNTHESIS | BETA-KETO-ESTERS | MACROCYCLIC KETONES | CHEMISTRY, MULTIDISCIPLINARY | STEREOSELECTIVE-SYNTHESIS | CONJUGATE ADDITION | Biological products industry
Journal Article
06/2016
Phys. Rev. D 94, 112009 (2016) Results are presented from searches for R-parity-violating supersymmetry in events produced in pp collisions at sqrt(s) = 8 TeV...
Physics - High Energy Physics - Experiment
Physics - High Energy Physics - Experiment
Journal Article